The Economics of Follow-On Drug Research and Development: Trends in Entry Rates and the Timing of Development ??? The Authors?? Reply
- 1 January 2005
- journal article
- Published by Springer Nature in PharmacoEconomics
- Vol. 23 (12) , 1193-1202
- https://doi.org/10.2165/00019053-200523120-00003
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Influence of Patients’ Requests for Direct-to-Consumer Advertised AntidepressantsJAMA, 2005
- Comment on ???The Economics of Follow-On Drug Research and Development: Trends in Entry Rates and the Timing of Development???PharmacoEconomics, 2005
- Are novel drugs more risky for patients than less novel drugs?Journal of Health Economics, 2004
- Pharmaceutical Pricing in a Regulated MarketThe Review of Economics and Statistics, 2003
- Do Pharmaceutical Sales Respond to Scientific Evidence?Journal of Economics & Management Strategy, 2002
- Measuring the Pace of New Drug Development in the User Fee ERADrug Information Journal, 2000
- Drug safety discontinuations in the United Kingdom, the United States, and Spain from 1974 through 1993: A regulatory perspectiveClinical Pharmacology & Therapeutics, 1995
- Drug discontinuations in the United Kingdom and the United States, 1964 to 1983: Issues of safetyClinical Pharmacology & Therapeutics, 1984
- Time‐cost tradeoffs in uncertain empirical research projectsNaval Research Logistics Quarterly, 1966